Angkai Life Technology

Founded in July 2019, Angkai Life was founded by Wang Qianghu, a postdoctoral fellow, professor and doctoral supervisor at the University of Texas Anderson Cancer Center. It is an innovative enterprise focused on the development and application of early tumor liquid detection technology. The team has a large number of high-quality R & D and clinical resources. While greatly improving the accuracy of early screening of tumors, it disruptively reduces the cost of detection, effectively breaks through the technical bottleneck of DNA methylation detection, and reconstructs clinical application scenarios. Sieves enter the field of general inspection.